Role of Ghrelin in Cancer
Journal Title: Iranian Journal of Blood and Cancer - Year 2016, Vol 8, Issue 1
Abstract
Cancer is one of the most fatal diseases in human beings which annually leads to death of 30000 individuals in Iran. Prevention, diagnosis and treatment of cancer is one of the major scientific challenges all around the world. It seems that increased incidence of several cancers such as colon and prostate and their mortality are connected with obesity. It is suggested that obesity and metabolic syndrome are associated with endocrine related cancers and ghrelin pathway may play a role in cancer progression. Ghrelin is a potent regulator of the growth hormone (GH)/ insulin-like growth factor-1 (IGF-1) axis, which is frequently implicated in the development of several neoplasms, including colon cancer. It has been reported that changed ghrelin level as a main regulator of energy homeostasis plays an important role in carcinogenesis. Also, antiproliferative effects of ghrelin in lung and breast carcinoma cell lines have been detected in some studies . In this paper, ghrelin and its role and function in cancer is discussed.
Authors and Affiliations
Robab Sheikhpour
Keywords
Related Articles
- EP ID EP254387
- DOI -
- Views 84
- Downloads 0
Preliminary Results of Allogenic Hematopoietic Stem Cell Transplantation of non-M3 Acute Myeloid Leukemia
Background: Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) is used as treatment of choice for patients with acute myeloid leukemia (AML). We aimed to evaluate the prognostic factors in 2-year overall sur...
Clinical Significance of Positive Platelet Immunofluorescence Assay in Adult Immune Thrombocytopenia: a Cross Sectional Study
Background: Immune thrombocytopenia is a hematologic disorder characterized by low platelet count and variable bleeding manifestations due to immune-mediated platelet destruction and/or suppression of platelet production...
The Comparison of Efficacy of Original Brand Deferoxamine with Generic Iranian Made Deferoxamine in Urinary Iron Excretion in Patients with Thalassemia Major
Background: Deferoxamine mesylate is still the conventional and well-known iron chelator for patients with thalassemia major. However, due to some marketing issues the well-known original brand, Desferal®, produced by No...
Retinoblastoma in Southwest Iran
Background: Retinoblastoma is the most common embryonic tumor of retina of children. This tumor include 3-4% of all children malignancies during the age range 0-14 years. In this study, we reported the incidence, therape...
Analgesic Effect of Distraction during Venipuncture in Children with Thalassemia
Background: Pain is described as the fifth vital sign, and inadequate pain management is linked to numerous immediate and long-term negative outcomes. Venipuncture is one of the most painful medical procedures in childre...